– Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, in a post-CDK inhibitor setting, compared with ...
Flow Space on MSN
Personalization is changing the future of healthcare: What it means
In practice, it could look like more efficiency-and feeling like you're being heard.
Earlier this month, Genentech offered countless academics and other researchers up to $125,000 in grants to generate papers ...
Roche/Genentech and AstraZeneca have the best-performing medical science liaison (MSL) teams in oncology, according to a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies ...
InvestorsHub on MSN
Genentech highlights new breast cancer and precision oncology data ahead of ASCO 2026 (RHHBY)
Roche’s Genentech unit is emphasizing next-generation breast cancer therapies, targeted oncology combinations and brain-penetrating treatments at ASCO 2026. Key Investor Takeaways ・Genentech, part of ...
Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche, announced ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® ...
Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...
Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/precigen-sees-q1-revenue-exceeding-18m-consensus-20-8m ...
Following an extensive inspection, the Environmental Protection Agency fined Genentech more than $158,000 for hazardous waste violations at a facility in California, the latest instance in which a ...
HOLLY SPRINGS, N.C. (WTVD) -- Biotech company, Genentech, broke ground on its new facility in Holly Springs on Monday morning. North Carolina Governor Josh Stein attended the ceremony.. Officials say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results